AARP, P4AD blast bill extending drugmakers’ exemption from Medicare negotiation
NegativeU.S News

AARP and Patients for Affordable Drugs Now (P4AD) are criticizing a new bill that would prolong the exemption for drugmakers from negotiating prices with Medicare. This is significant because it could lead to higher drug costs for seniors and undermine efforts to make medications more affordable. The organizations argue that extending this exemption is detrimental to patients who rely on Medicare for their healthcare needs.
— Curated by the World Pulse Now AI Editorial System